echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Yangtze River "overweights" 1 billion anti-epileptic drugs!

    Yangtze River "overweights" 1 billion anti-epileptic drugs!

    • Last Update: 2021-08-07
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    A few days ago, the official website of CDE showed that the Levetiracetam tablets of Nanjing Hailing Pharmaceutical of Yangtze River Pharmaceutical Group were accepted for the application of imitation 4 types of listing


    Data show that Levetiracetam tablets are developed by UCB (UCB) for the treatment of partial seizures (with or without secondary generalized seizures) in adults and children over 4 years of age with epilepsy; for adults And add-on treatment for general tonic-clonic seizures in adolescents over 16 years of age with epilepsy


    Sales of Levetiracetam Tablets in Physical Pharmacies in Chinese Cities in Recent Years (Unit: RMB 10,000)

    Source: Mi Nei.


    According to data from Meinenet, in 2020, the total sales of Levetiracetam tablets in Chinese urban public hospitals, county-level public hospitals, urban community centers and township health centers (Chinese public medical institutions) terminals and Chinese urban physical pharmacies terminals exceed 10 100 million yuan, Utimes has the largest market share


    Source: Meinenet MED2.


    At present, Levetiracetam tablets have 9 manufacturers including Zhejiang Jingxin Pharmaceutical, Zhejiang Prokangyu Pharmaceutical, and Shenzhen Xinlitai Pharmaceutical


    In addition, 8 companies have submitted applications for listing for this product and are under review and approval.


    Source: CDE official website, Minet.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.